Watch ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.

The nature of communicable diseases results in unique epidemiological characteristics that must be accounted for when considering the epidemiological, clinical, and economic consequences of interventions that modify transmission. These interventions clearly include vaccines, but also drug treatments that may reduce the duration of infectiousness.

This webinar outlines the unique epidemiological characteristics of communicable diseases and demonstrates how correctly accounting for these in clinical and economic assessments of interventions can capture the full value of these interventions. Some of the challenges faced when performing these analyses are also addressed.

Key Topics Include:

  • Understanding infectious disease modeling
  • Why infectious disease modeling is needed
  • Challenges associated with infectious disease modeling
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.


To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.


Senior Consultant
Global Health Economics, Outcomes Research and Epidemiology

Marija Zivkovic-Gojovic is experienced in using various types of dynamic modeling algorithms, with expertise in agent-base modeling. Her work includes modeling various disease dynamics like influenza, pertussis, HPV, HIV, HepB, HepC, and COVID-19 and health-economic modeling with an emphasis on health-economic evaluation of vaccine applications.

Lead Health Economist & Epidemiologist
Global Health Economics, Outcomes Research and Epidemiology

Richard Pitman has over 30 years experience in the epidemiology, burden of illness, and mathematical modeling of infectious diseases, particularly relating to the cost effectiveness of interventions and policy issues. Disease area expertise includes influenza, SARS, rotavirus, respiratory syncytial virus, tuberculosis, directly transmitted childhood infections, and HIV.

Global Health Economics, Outcomes Research and Epidemiology

Pragya Khurana has focused on epidemiology and data analytics projects within the Real-World Evidence space. She has experience in multiple therapeutic areas, including oncology and infectious diseases. Pragya has a strong understanding of epidemiologic study design and conduct of analysis. She has provided support and insight at various study stages.

Production Partner


ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients - reducing time to market, reducing cost and increasing quality.

Additional Content From ICON

Social Media Data: Opportunities and Insights for Clinical Research

Social Media Data: Opportunities and Insights for Clinical Research

Hear four experts from ICON and Kap Code provide insights on how to collect, use, analyze, and interpret social media data in different contexts. These experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.

Additional Content From HealthEconomics.Com

Related Content